Europe - Euronext Milan - BIT:1LLY - US5324571083 - Common Stock
Taking everything into account, 1LLY scores 6 out of 10 in our fundamental rating. 1LLY was compared to 55 industry peers in the Pharmaceuticals industry. While 1LLY has a great profitability rating, there are some minor concerns on its financial health. 1LLY is valued quite expensively, but it does show have an excellent growth rating. With these ratings, 1LLY could be worth investigating further for growth investing!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.52 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.31 | ||
| Fwd PE | 32.73 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 159.27 | ||
| EV/EBITDA | 37.39 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.64% |
ChartMill assigns a fundamental rating of 6 / 10 to 1LLY.MI.
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (1LLY.MI). This can be considered as Overvalued.
ELI LILLY & CO (1LLY.MI) has a profitability rating of 9 / 10.
The Earnings per Share (EPS) of ELI LILLY & CO (1LLY.MI) is expected to grow by 84.93% in the next year.
The dividend rating of ELI LILLY & CO (1LLY.MI) is 4 / 10 and the dividend payout ratio is 28.28%.